glutamic acid has been researched along with Autoimmune Demyelinating Diseases, Central Nervous System in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberdi, E; Domercq, M; Matute, C; Pérez-Cerdá, F; Pérez-Samartín, A; Sánchez-Gómez, MV; Torre, I | 1 |
1 other study(ies) available for glutamic acid and Autoimmune Demyelinating Diseases, Central Nervous System
Article | Year |
---|---|
Activation of kainate receptors sensitizes oligodendrocytes to complement attack.
Topics: Animals; Animals, Newborn; Antioxidants; Calcium; Cell Death; Cell Membrane; Cells, Cultured; Complement System Proteins; Demyelinating Autoimmune Diseases, CNS; Dose-Response Relationship, Drug; Glutamic Acid; Male; Nerve Fibers, Myelinated; Neurotoxins; Oligodendroglia; Optic Nerve; Oxidative Stress; Patch-Clamp Techniques; Polynucleotide Adenylyltransferase; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid | 2006 |